Supplier profile
Bristol-Myers Squibb; S.A.
Every public-sector award we hold for this supplier, across Spain, France, Luxembourg and Portugal, from 28 May 2008 to 30 Sept 2026.
Awards won
306
all time
Attributed value
€398.5m
68 shared, unvalued
Buyers
170
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Centro Hospitalar Lisboa Norte; EPE | 13 | €1.8m |
| Centro Hospitalar Lisboa Norte, EPE | 12 | €2.0m |
| Osakidetza | 10 | €27.1m |
| Corporació Sanitària Parc Taulí | 7 | €2.3m |
| OSAKIDETZA - Servicio Vasco de Salud - Organización Central | 7 | €93.8m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 5 | €3.5m |
| Servicio Madrileño de Salud, Hospital Universitario 12 de Octubre | 5 | €1.9m |
| Centro Hospitalar Lisboa Norte, E. P. E. | 4 | €1.5m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 4 | €459k |
| Ente Público Hospital Universitario de Fuenlabrada | 4 | €1.5m |
What they win
Awards
Showing 26–50 of 306 awards we hold
- Lote 67 del acuerdo marco adjudicado para el suministro de los medicamentos de uso humano tipo II (Exclusivos), con destino al Servicio Canario de l Salud, a la empresa BRISTOL MYERS SQUIBB, S.A., expediente 50/F/25/SU/GE/N/240. ↗Dirección Gerencia del Complejo Hospitalario Universitario de Canarias€59kawarded 13 Oct 2025
- Lote 63 del acuerdo marco adjudicado para el suministro de los medicamentos de uso humano tipo II (Exclusivos), con destino al Servicio Canario de l Salud, a la empresa BRISTOL MYERS SQUIBB, S.A., expediente 50/F/25/SU/GE/N/240. ↗Dirección Gerencia del Complejo Hospitalario Universitario de Canarias€7kawarded 13 Oct 2025
- Lote 64 del acuerdo marco adjudicado para el suministro de los medicamentos de uso humano tipo II (Exclusivos), con destino al Servicio Canario de l Salud, a la empresa BRISTOL MYERS SQUIBB, S.A., expediente 50/F/25/SU/GE/N/240. ↗Dirección Gerencia del Complejo Hospitalario Universitario de Canarias€139kawarded 13 Oct 2025
- Spain – Various medicinal products – Suministros ( CCA. +IA83G8) ↗Servicio Andaluz de Salud. Hospital Universitario de Jaénshared awardawarded 8 Oct 2025
- Suministro de medicamentos exclusivos de la empresa BRISTOL MYERS SQUIBB S.A., ↗Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria€327kawarded 1 Oct 2025
- Suministro de Medicamentos de Uso Humano II (Exclusivos), 23/S/24/SU/DG/N/AM22, con destino al Servicio de Farmacia del Hospital Universitario Ntra. Sra. De Candelaria, suscrito en el ámbito del Servicio Canario de Salud. ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€2.1mawarded 18 Sept 2025
- Spain – Various medicinal products – Suministro de Medicamentos de Uso Humano tipo II (Medicamentos Exclusivos) con destino al Servicio Canario de la Salud. ↗Dirección General de Recursos Económicos del Servicio Canario de la Saludshared awardawarded 8 Aug 2025
- Suministro de Medicamentos de Uso Humano tipo II (Medicamentos Exclusivos) con destino al Servicio Canario de la Salud. ↗Dirección General de Recursos Económicos del Servicio Canario de la Salud€17.8mawarded 7 Aug 2025
- Spain – Pharmaceutical products – AM SUMINISTROS (CONTR 2025 0000292876) ↗HOSPITAL UNIVERSITARIO REINA SOFIAshared awardawarded 29 Jul 2025
- Spain – Antineoplastic agents – Suministro Medicamentos exclusivos con principios activos nivolumab, ipilimumab, abatacept, fedratinib, mavacamten, deucravacitinib y azacitidina en comprimidos ↗Servicio Murciano de Salud - Junta de Compras€15.2mawarded 17 Jul 2025
- Suministro Medicamentos exclusivos con principios activos nivolumab, ipilimumab, abatacept, fedratinib, mavacamten, deucravacitinib y azacitidina en comprimidos ↗Servicio Murciano de Salud - Junta de Compras€15.2mawarded 16 Jul 2025
- Spain – Pharmaceutical products – HUELVA 6º CBAM 995/20 AM 2207/20 BRISTOL MYERS SQUIBB S.A. ↗Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez€1.0mawarded 18 Jun 2025
- Spain – Pharmaceutical products – Suministro de Mavacamten (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€6.5mawarded 25 Mar 2025
- Sum medicamentos exclusivos Amgen, Bristol Myers, Merck Sharp y Toche Farma ↗Gerencia de Atención Integrada de Cuenca€34kawarded 13 Mar 2025
- Spain – Pharmaceutical products – Contrato de suministros CONTR 2024 0001031923 ↗Servicio Andaluz de Salud. Área Hospitalaria Virgen del Rocío.awarded 10 Mar 2025
- Suministro de Medicamentos Exclusivos de la Gerencia de Atención integrada de Almansa ↗Gerencia de Atención Integrada de Almansa€444kawarded 6 Feb 2025
- Luxembourg – Various medicinal products – Centrale d'achat FHL: fourniture d’anticorps monoclonaux. ↗Fédération des Hôpitaux Luxembourgeois (FHL)shared awardawarded 20 Dec 2024
- Spain – Pharmaceutical products – Suministro de Idecabtagén Vicleucel (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€18.3mawarded 5 Nov 2024
- ta2025 suministro del principio activo nivolumab (opdivo) - hcd derivado de a.m. 381/2022 (01-01-2025 hasta 15-12-2025)
 ↗Inspección General de Sanidad de la Defensa€115kawarded 31 Oct 2024
- Spain – Pharmaceutical products – ACUERDO MARCO POR PROCEDIMIENTO NEGOCIADO SIN PUBLICIDAD POR EXCLUSIVIDAD (SEGÚN ART. 168.2) PARA EL SUMINISTRO DE 93 LOTES DE MEDICAMENTOS EXCLUSIVOS PARA TODOS LOS HOSPITALES DEPENDIENTES DEL SERMAS. ↗SERVICIO MADRILEÑO DE SALUDshared awardawarded 23 Oct 2024
- Spain – Pharmaceutical products – SUMINISTRO DE PRODUCTOS SANITARIOS PARA VENTILOTERAPIA NO INVASIVA Y OXIGENOTERAPIA ↗SERVICIO MADRILEÑO DE SALUDshared awardawarded 23 Oct 2024
- Ta2025 sum l134 abatacept - orencia - derivado del a. marco 27/2022 de medicamentos exclusivos del sermas - hcd
 ↗Inspección General de Sanidad de la Defensa€48kawarded 30 Sept 2024
- L103 ipilimumab - yervoy - am a. m. 27/2022 medicamentos exclusivos sermas - hcd
 ↗Inspección General de Sanidad de la Defensa€6kawarded 16 Sept 2024
- L 134 abatacept - orencia - derivado del a. marco 27/2022 de medicamentos exclusivos del sermas - hcd
 ↗Inspección General de Sanidad de la Defensa€13kawarded 16 Sept 2024
- Spain – Pharmaceutical products – Suministro de Triamcinolona Acetónido (DOE) y Abatacept (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.5mawarded 31 Aug 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Bristol Myers Squibb413 awards · £3.3m
- BRISTOL-MYERS SQUIBB S.R.L.124 awards
- Bristol-Myers Squibb AB11 awards
- Bristol Myers Squibb, S. L.4 awards
- BRISTOL-MYERS SQUIBB, S.L.U.2 awards
- Bristol MYERS Squibb SpA2 awards
- Bristol-Myers Squibb (Finland) AB1 award
- Bristol Myers Squibb NV1 award
- Bristol-Myers Squibb Oy Ab1 award
- bristol myers squibb sarl1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.